💨 Abstract

Thyrocare Technologies Limited, a leading healthcare diagnostics company, reported Q4FY25 results with a 21% year-over-year growth in revenue to INR 187.2 crore. Normalized EBITDA increased by 78% to INR 65.3 crore, and PAT grew by 88% to INR 32.5 crore.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖

Powered by MessengerX.io